Lymph node metastasis was an independent risk factor of lymphedema of the upper limb; lymph node metastasis and Ki-67 expression level were independent factors that impacted pathologic complete response rate of neoadjuvant chemotherapies. This evidence concerns the gene MKI67 and metastatic malignant neoplasm in the lymph nodes.